Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - prednisolone acetate - ophthalmic suspension - prednisolone acetate 1 %w/v - prednisolone - prednisolone - for steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - fluorometholone - ophthalmic suspension - fluorometholone 0.1 %w/v - fluorometholone - fluorometholone - to treat eye inflammation.

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - brimonidine tartrate - ophthalmic solution - brimonidine tartrate 0.15 %w/v - brimonidine - brimonidine - alphagan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Israel - English - Ministry of Health

perrigo israel pharmaceuticals ltd - bifonazole; urea - ointment - bifonazole 1 %; urea 40 % - imidazole and triazole derivatives - for nail stripping and antifungal treatment of fungal infections of the finger nails and toe nails.

Israel - English - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole - paste - clotrimazole 1 % - imidazole and triazole derivatives - for treatment of fungal nappy rash in children, that lasts over 72 hours.

United Kingdom - English - myHealthbox

rosemont pharmaceuticals ltd - rivastigmine hydrogen tartrate - oral solution - 2mg for ml - psychoanaleptics, anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia; symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

Ireland - English - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - methotrexate disodium - oral solution - 2 mg/ml - methotrexate - antineoplastic and immunomodulating agents, antimetabolites, folic acid analogues - it is indicated in the following oncological indications: the maintenance treatment of acute lymphocytic leukaemia (all) in children and adults; the treatment of malignant trophoblastic tumours and for the treatment of severe active rheumatoid arthritis in adults and the treatment of severe forms of psoriasis vulgaris including chronic plaque psoriasis, erythrodermic psoriasis, psoriatic arthritis and pustular psoriasis which are not responsive to other conventional therapies such as phototherapy, puva and retinoids.

United Kingdom - English - myHealthbox

rosemont pharmaceuticals ltd - risperidone - oral solution - 1mg/ml - other antipsychotics - it is indicated for the treatment of schizophrenia; for the treatment of moderate to severe manic episodes associated with bipolar disorders; for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer's dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others.; for the short-term symptomatic treatment (up to 6 weeks) of persistent aggression in conduct disorder in children from the age of 5 years and adolescents with subaverage intellectual functioning or mental retardation diagnosed according to dsm-iv criteria, in whom the severity of aggressive or other disruptive behaviours require pharmacologic treatment.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferndale pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

Israel - English - Ministry of Health

rafa laboratories ltd - netupitant; palonosetron as hydrochloride - capsules - netupitant 300 mg; palonosetron as hydrochloride 0.50 mg - palonosetron, combinations - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.